WBJ: New York health-tech company Claritev moves headquarters to Northern Virginia
By Sara Gilgore – Staff Reporter,…
Read MoreQIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN…
Read MoreAscentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)
ROCKVILLE, Md. and SUZHOU, China, March…
Read MoreUSP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients
USP publishes Vulnerable Medicines List to…
Read MoreREGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases
ROCKVILLE, Md., March 4, 2025 /PRNewswire/ -- REGENXBIO…
Read MoreIGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection
POTOMAC, MD / ACCESS Newswire / March 4,…
Read MoreGeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a…
Read MoreVenture Valkyrie: Tough Love for Women’s Health Entrepreneurs Raising Venture Money
Since I have been raising and…
Read MoreBioBuzz: TEDCO’s Impact on Maryland’s Entrepreneurial Ecosystem
By Annabel Baldy - In November’s What’s the…
Read MoreGEN: Former NIH Director Francis Collins Praises the Institution as He Abruptly Departs After Three Decades
By Kevin Davies, PhD - March…
Read MoreGEN: FDA Accepts for Review Precigen RRP Gene Therapy Candidate
By Alex Philippidis - February 26,…
Read MoreTNF Pharmaceuticals Launches Phase 2b Trial for First Oral TNF-Alpha Inhibitor to Combat Muscle Loss and Frailty
BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA)…
Read MoreCityBiz – Protenus: From Accelerator to Acquisition
Protenus, a leading healthcare compliance analytics…
Read More